Skip to main content
. 2021 Jun 30;10:98. doi: 10.1186/s13756-021-00969-w

Table 5.

Differences of characteristics of BSI burn patients receiving appropriate and inappropriate empirical antimicrobial therapy

Variable Empirical antimicrobial therapy
Appropriate
n = 79
Inappropriate
n = 57
p-value
Male 59 (74.7) 41 (71.9) 0.719
Age (years) (median, IQR) 47 [34,54] 46 [38,56] 0.601
Comorbidities 19 (24.1) 15 (26.3) 0.763
Type of burn
 Flame 70 (88.6) 46 (80.7) 0.199
 Chemical 2 (2.5) 3 (5.3) 0.404
 Hyperthermia liquid 5 (6.3) 7 (12.3) 0.227
 Other 2 (2.5) 1 (1.8) 0.761
%TBSA
 20–39 16 (20.3) 11 (19.3) 0.341
 40–59 19 (24.1) 13 (22.8)
 60–79 23 (29.1) 10 (17.5)
 ≥ 80 21 (26.6) 23 (40.4)
 Accompanying third degree burns 73 (92.4) 53 (93.0) 0.899
 Inhalation injury 51 (64.6) 29 (50.9) 0.110
 Mechanical ventilation 48 (60.8) 34 (59.6) 0.896
Coinfections before bacteremia
 Skin infection 65 (82.3) 37 (64.9) 0.021
 Pneumonia 38 (48.1) 19 (33.3) 0.085
 CVC infection 24 (30.4) 14 (24.6) 0.456
 UTI 3 (3.8) 3 (5.3) 0.681
 AKI 9 (11.4) 13 (22.8) 0.074
 Septic shock 9 (11.4) 9 (15.8) 0.455
 MODS 7 (8.9) 12 (21.1) 0.043
 Hospital length of stay, days (median, IQR) 51 [34,68] 47 [30,66] 0.642
 Inappropriate definitive antimicrobial therapy 3 (3.8) 13 (22.8) 0.001
 Outcomes
 30-day mortality 6 (7.6) 10 (17.5) 0.076
 60-day mortality 11 (13.9) 14 (24.6) 0.114

BSI bloodstream infection, IQR interquartile range, TBSA total body surface area, CVC central venous catheter, UTI urinary tract infection, AKI acute kidney injury, MODS multiple organ dysfunction syndrome